Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial
- PMID: 25050518
- DOI: 10.1055/s-0034-1384536
Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial
Abstract
Objective: Osteoarthritis (OA) is a degenerative joint disease associated with inflammation. The present study aimed to determine changes in serum levels of inflammatory biomarkers in OA patients whose clinical symptoms were improved as a result of supplementation with curcuminoids.
Methods: This study was a randomized double-blind placebo-control parallel-group clinical trial in which 40 subjects with mild-to-moderate degree knee OA were randomly allocated to receive either pure curcuminoids (1,500 mg/day in 3 divided doses; n=19) or matched placebo (n=21) for 6 weeks. In order to enhance the bioavailability of curcuminoids, piperine (15 mg/day) was added to the treatment regimen. Serum levels of interleukins 4 (IL-4) and 6 (IL-6), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and high-sensitivity C-reactive protein (hs-CRP), together with erythrocyte sedimentation rate (ESR) were determined at baseline as well as at the end of trial.
Results: Serum concentrations of IL-4 (p=0.001), IL-6 (p=0.006) and hs-CRP (p=0.004) were significantly reduced in the curcuminoid group whilst serum levels of TNF-α and TGF-β and mean ESR remained unaltered by the end of trial (p>0.05). In the placebo group, serum concentrations of IL-4 (p=0.001), IL-6 (p=0.003), TNF-α (p=0.003) and TGF-β (p=0.005) were significantly reduced but mean hs-CRP and ESR values remained statistically unchanged (p>0.05). Comparison of the magnitude of changes in the evaluated inflammatory biomarkers did not indicate any significant difference between the study groups (p>0.05).
Conclusion: Significant improvement in clinical symptoms of OA in curcuminoid-treated subjects cannot be attributed to the systemic anti-inflammatory effects of these phytochemicals.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.Pharmacol Res. 2016 Sep;111:394-404. doi: 10.1016/j.phrs.2016.07.004. Epub 2016 Jul 5. Pharmacol Res. 2016. PMID: 27392742 Review.
-
Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial.J Diet Suppl. 2016;13(2):209-20. doi: 10.3109/19390211.2015.1008611. Epub 2015 Feb 17. J Diet Suppl. 2016. PMID: 25688638 Clinical Trial.
-
Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.Clin Nutr. 2015 Dec;34(6):1101-8. doi: 10.1016/j.clnu.2014.12.019. Epub 2015 Jan 7. Clin Nutr. 2015. PMID: 25618800 Clinical Trial.
-
Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.Phytother Res. 2014 Oct;28(10):1461-7. doi: 10.1002/ptr.5149. Epub 2014 Mar 19. Phytother Res. 2014. PMID: 24648302 Clinical Trial.
-
Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.Phytother Res. 2014 May;28(5):633-42. doi: 10.1002/ptr.5045. Epub 2013 Aug 7. Phytother Res. 2014. PMID: 23922235 Review.
Cited by
-
Curcumin and Resveratrol: Nutraceuticals with so Much Potential for Pseudoachondroplasia and Other ER-Stress Conditions.Biomolecules. 2024 Jan 27;14(2):154. doi: 10.3390/biom14020154. Biomolecules. 2024. PMID: 38397390 Free PMC article. Review.
-
The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications.J Neurogastroenterol Motil. 2023 Oct 30;29(4):409-418. doi: 10.5056/jnm23065. J Neurogastroenterol Motil. 2023. PMID: 37814431 Free PMC article. Review.
-
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14. ACS Pharmacol Transl Sci. 2023. PMID: 37082752 Free PMC article. Review.
-
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?ACS Omega. 2023 Mar 13;8(12):10713-10746. doi: 10.1021/acsomega.2c07326. eCollection 2023 Mar 28. ACS Omega. 2023. PMID: 37008131 Free PMC article. Review.
-
Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials.Int J Mol Sci. 2023 Feb 24;24(5):4476. doi: 10.3390/ijms24054476. Int J Mol Sci. 2023. PMID: 36901908 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous